Artiva Biotherapeutics Company
Artiva Biotherapeutics is a biotech company focused on developing and commercializing allogeneic natural killer (NK) cell therapies.
Investors
Technology:
Cell therapy, Cell-based gene therapy
Industry:
Private
Headquarters:
San Diego, California, United States
Founded Date:
2019-01-01
Employees Number:
11-50
Funding Status:
Early Stage Venture
Investors Number:
16
Total Funding:
198000000
Estimated Revenue:
Less than $1M
Last Funding Date:
2021-02-26
Last Funding Type:
Series B
Register and Claim Ownership